Apolipoprotein News and Research

RSS

Genetic code doesn't dictate whether a person is guaranteed to develop Alzheimer's

The colour of our eyes or the straightness of our hair is linked to our DNA, but the development of Alzheimer's disease isn't exclusively linked to genetics, suggest recently published findings.

11 Dec 2019

Research shows how high levels of blood fat induce inflammation and organ damage

Viral and bacterial infections are not the only causes of inflammation of body tissue. It has been known for some time that certain fat molecules in our bloodstream can also trigger an inflammatory response.

9 Dec 2019

Gene linked to Alzheimer’s plays indirect role in increasing delirium risk

Marked by acute temporary confusion, disorientation and/or agitation, postoperative delirium is the most common post-surgical complication in older adults, striking as many as half of adults older than 65 who undergo high-risk procedures such as cardiac surgery or hip replacements.

21 Nov 2019

Longitudinal study finds no cognitive decline or memory loss related to statin use

A study has demonstrated that the rate of memory decline in users of statin, was not significantly different to a control.

19 Nov 2019

Key Alzheimer's gene variants act differently among Caribbean Hispanics based on ancestry

Researchers looking to uncover the mysteries of Alzheimer's disease have revealed new insights from old variants.

15 Nov 2019

Alzheimer's Association's 2020 Zenith Fellows awards support new approaches to treatment

The Alzheimer's Association today announced a new investment of more than $1.3 million in three research projects focused on more effective treatments and protection factors for Alzheimer's disease and other dementias.

2 Nov 2019

Amyloid-β protein misfolding proves to be strong risk prediction marker for Alzheimer's

In symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicated a considerably higher risk of Alzheimer's disease - up to 14 years before a clinical diagnosis was made.

15 Oct 2019

Diabetic mice benefit from increased ‘good’ cholesterol levels

A new study has looked into the artificial increase in the level of 'good' cholesterol and its link to the reversal of atherosclerosis in arteries.

30 Sep 2019

'Good' cholesterol reverses atherosclerosis in the blood vessels of mice with diabetes

Increasing levels of a simplified version of "good" cholesterol reversed disease in the blood vessels of mice with diabetes, a new study finds.

30 Sep 2019

Protein prevalent in older people interferes with bone healing

Broken bones are a bigger deal the older you are: even after they've healed, the bones of older people are weaker and more likely to re-fracture. And since more than 6 million Americans break a bone each year, figuring out how to help people heal better would make a big difference.

19 Sep 2019

Strongest genetic risk factor for Alzheimer’s disease impairs function of human microglia

A study carried out with a new human stem cell-derived model reveals that the most prevalent genetic risk factor of Alzheimer’s disease (AD), apolipoprotein E4 (APOE4), impairs the function of human brain immune cells, microglia. These findings pave the way for new, effective treatment approaches for AD. The results were published in Stem Cell Reports.

17 Sep 2019

Adults carrying Alzheimer's risk gene have harder time accessing recently acquired knowledge

Adults carrying a gene associated with a higher risk of Alzheimer's disease had a harder time accessing recently acquired knowledge, even though they didn't show any symptoms of memory problems, according to findings published in a joint Baycrest-University of Oxford study.

23 Aug 2019

Human apolipoprotein E promotes hepatitis B virus infection

Human apolipoprotein E (apoE) promotes hepatitis B virus (HBV) infection and production, according to a study published DATE in the open-access journal PLOS Pathogens by Luhua Qiao and Guangxiang (George) Luo of the University of Alabama at Birmingham School of Medicine.

From PLOS ONE 13 Aug 2019

Researchers test new drug to treat patients with chylomicronemia syndrome

People with familial chylomicronemia syndrome are born with a genetic mutation that means they can't produce an enzyme called lipoprotein lipase.

9 Aug 2019

APOE gene variant may be protective and prolong life, finds study

A new study of 38,537 persons of European ancestry suggests that a rare variation of a gene called APOE may be protective and prolong life, in sharp contrast to a more widely studied APOE variant that increases risk of death.

7 Aug 2019

Glowing cholesterol helps researchers to fight cardiovascular disease

A newly developed technique that shows artery clogging fat-and-protein complexes in live fish gave investigators from Carnegie, Johns Hopkins University, and the Mayo Clinic a glimpse of how to study heart disease in action.

31 Jul 2019

Randox unveils innovative test for risk assessment of cardiovascular disease

Global diagnostics company Randox Laboratories has unveiled an innovative new test for the risk assessment of cardiovascular disease at this year's AACC Clinical Lab Expo in Anaheim, California.

26 Jul 2019

Alzheimer's gene may affect cognitive health before adulthood, study finds

The Apolipoprotein E (APOE) is a major cholesterol carrier that aids in lipid transport and injury repair in the brain. It packages cholesterol and other fats and moves them through the bloodstream. APOE polymorphic alleles are the major genetic factors for the risk of Alzheimer’s disease (AD).

19 Jul 2019

Adults with family history of Alzheimer’s have learning impairments, study finds

Adults with a first-degree relative with Alzheimer's disease perform more poorly on online paired-learning tasks than adults without such a family history, and this impairment appears to be exacerbated by having diabetes or a genetic variation in the apolipoprotein E (APOE) gene linked to the disease.

10 Jul 2019

Study uncovers new way to identify driver genes important for cancer progression

Until now, researchers believed recurrent mutations (hotspot mutations) in cancer tumors were the important mutations (driver mutations) that promoted cancer progression.

29 Jun 2019